ClinicalTrials.gg
RecruitingNCT06851273GSHimplementUpdated May 7, 2026

Guided Self Help for Eating Disorders Implementation Study

An interventional study of Guided Self Help Family Based Therapy (GSH FBT) in Eating Disorders, sponsored by McMaster University. Recruiting at 1 site in Canada. Open to participants aged 12 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by McMaster University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Ages
12 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 41 studies in Feeding and Eating Disorders with a site in Canada — 11 open to participants now, 12 under way, none of them phase 3. Feeding and Eating Disorders · Canada.

Planned enrollment
10th of 35
90 · median 60
Started
2026
with 3 others
No phase
30 of 41
7 open now
Primary completion
2027-08
later than 7 of 11 live
Registered
34th of 41
by date
Lead sponsor
7 of 41
McMaster University

Among the 41 studies in Feeding and Eating Disorders with a site in Canada, this one is the 10th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2026, is one of 30 with no phase, reaches primary completion later than 7 of the 11 other live ones, and was the 34th registered.

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 151 are open to participants now.

Browse Feeding and Eating Disorders studies →

Open to participants now

11 of the 41 studies in Feeding and Eating Disorders with a site in Canada are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 99 Feeding and Eating Disorders studies recruiting now, 31 (31%) set no upper age limit and 66 (67%) stop at 75 or younger; 45 take children under 18; 20 take healthy volunteers.

This study: 12 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 41 studies in Feeding and Eating Disorders with a site in Canada, or all of them as a file.
02

Study summary

Eating disorders are amongst the most understudied illnesses affecting young women in Canada. Further, mortality rates are amongst the highest of all psychiatric illnesses. Despite their high prevalence and mortality rates, research into adolescent eating disorders is underfunded in Canada. In addition to the problem of research underfunding, healthcare system underfunding exists - creating long waiting lists and fragmented care for children and youth with eating disorders. More efficient treatments are urgently needed to reduce wait times and provide expedited care to adolescents on eating disorder waitlists. The current study aims to assess whether implementing a virtual parent-lead therapy, Guided Self Help Family-Based Therapy (GSH FBT) might alleviate wait times for eating disorder services and also reduce eating disorder symptomatology in young people with anorexia nervosa. This study also aims to determine the experiences of both families and medical teams of GSH FBT implementation as an intervention.

Read the detailed description

The most widely used evidence-based treatment for children and adolescents with eating disorders is Family-Based Treatment (FBT). Similarly, Guided Self-Help FBT (GSH FBT) is a virtual treatment, adapted using FBT principles, that involves a therapist "coach" and a video platform for parents. Therapeutic challenges such as treatment fidelity could be partially mitigated with a model, such as GSH FBT, in which essential material is delivered by video or written material, standardizing the treatment and ensuring that key components are delivered. Given the surging wait list times for adolescent eating disorder treatment, GSH FBT is emerging as a promising, more efficient alternative to longer-term FBT and FBT-V. This study is aimed at examining the implementation of GSH FBT for pediatric patients with eating disorders across nine provinces in Canada using a mixed methods design. To implement this new model of care, the investigators will use implementation teams at each site along with GSH FBT provider training and consultation. The investigators will evaluate the implementation approach using qualitative and quantitative methods including fidelity assessments, examination of wait times, patient, family, and provider outcomes, as well as the overall experience of the implementation of the intervention. Experience of implementation will be assessed using qualitative measures such as semi-structured interviews and focus groups.

03

Conditions studied

  • Eating Disorders

Keywords

  • Anorexia nervosa
  • Mental disorders
  • Adolescent eating disorders
  • Psychotherapy intervention
  • Guided self help therapy
  • Family-based treatment
04

Who can participate

Ages eligible
12 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Family including an adolescent with a confirmed diagnosis of Anorexia nervosa according to criteria.
  • Access to computer and internet connection
  • Have the capacity to speak, write, and understand English or French
  • Therapist/coaches are licensed mental health clinician with experience in eating disorder treatment

Exclusion criteria

Exclusion Criteria:

  • Adolescent has a current physical or mental disorder that requires hospitalization and/or prohibits the use of psychotherapy
  • Adolescent has a current dependence on drugs or alcohol
  • Adolescent has a current physical condition known to influence weight or eating (pregnancy, diabetes mellitus)
  • Adolescent has expected body weight of less than 75%
  • Adolescent/family has undergone four or more sessions of FBT for anorexia nervosa at any time
  • Does not have the capacity to speak, write, and understand English or French
  • Does not have access to computer and internet connection
  • Professionals are not licensed mental health professionals with experience in eating disorder treatment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Parents who have a child with anorexia nervosa

    Each participant will receive a series of pre-recorded videos, an electric scale, and a therapy manual ("Help Your Teenager Beat an Eating Disorder"). This will include content on empowering parents to renourish their child and interrupt binge/purge behaviors.

    Behavioral: Guided Self Help Family Based Therapy (GSH FBT)

Interventions

  • BehavioralGuided Self Help Family Based Therapy (GSH FBT)

    Each family will participate in ten virtual sessions of GSH FBT with a trained GSH practitioner local to their provincial study site. Parents will meet their coach for a 60-minute onboarding session where the parents/caregivers are familiarized with the video platform used in treatment. Then, the treatment consists of ten virtual 20-minute sessions over 6 months. In GSH FBT, the parents weigh the adolescent patient prior to the session, on the same day as the session, and report the weight to the coach. Throughout treatment, parents have access to an online platform with a series of videos that outline the core components of FBT: the urgency to act, parental empowerment, medical complications, strategies to use during and after mealtime, and how to externalize the illness. In line with GSH approaches, coach-therapists direct parents to watch or review videos and text content rather than directly affecting behavioral change.

06

What researchers measure

Primary outcomes

  1. Implementation success at participating sites, as measured by fidelity to GSH FBT model

    Fidelity of therapists will be measured via administration of a self-reporting fidelity questionnaire piloted in a previous GSH FBT feasibility study. This questionnaire includes nine yes/no questions that gauge whether the therapist was adherent to GSH FBT principles: 1) ensuring only parents are present; 2) ensuring the adolescent is not present; 3) asking parents questions/comments about course materials; 4) avoiding direct orchestration of behavioural change; 5) referencing course materials during the session; 6) focusing the session on treatment; 7) assigning homework appropriately; and 8) \& 9) verifying session length. Videos will also be monitored regularly for fidelity via expert review.

    Time frame: Immediately after each session throughout the 10-week protocol

Secondary outcomes

  1. Changes in severity of eating disorder symptoms

    Changes in severity of eating disorder symptoms will be assessed using the Eating Disorder Examination Questionnaire (EDEQ), a 28-item standardized questionnaire that measures the severity of symptoms of eating disorders. The EDEQ is scored using a 7-point, forced-choice rating scale (0-6) with scores of 4 or higher indicative of clinical range and severity of the illness.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  2. Changes in wait times as result of implementation approach

    Changes in wait time for service will be assessed by asking site administrators to provide wait time for service (in days) and an estimate of number of adolescents waiting for eating disorder services.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  3. Changes in severity of depressive symptoms

    Changes in severity of depressive symptoms will be assessed using the Beck Depression Inventory (BDI), a 21-item questionnaire used to measure the severity of depressive symptoms. Minimum score is 0, maximum score is 63.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  4. Changes in anxiety symptoms

    Changes in severity of anxiety symptoms will be assessed using the Beck Anxiety Inventory (BAI), a 21-item questionnaire used to measure the severity of anxiety symptoms. Minimum score is 0, maximum score is 63.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  5. Changes in obsessional thinking and compulsive behaviours (linked to eating disorder symptomatology)

    Changes in severity of obsessional thinking and compulsive behaviours (linked to eating disorder symptomatology) will be assessed using the Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS), It includes a comprehensive checklist of 21 preoccupations and 44 rituals related to food, eating, weight, shape, and appearance. Each item is rated on a scale from 0 to 4, with 0 indicating no symptoms and 4 indicating very severe symptoms. The total score is the sum of these individual ratings. Therefore, the minimum possible score is 0 (indicating no symptoms), and the maximum possible score is 260 (indicating the most severe symptoms).

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  6. Changes in obsessional thinking and compulsive behaviours

    Changes in severity of obsessional thinking and compulsive behaviours will be assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS-II), a self-report questionnaire assessing obsessions and compulsions separately from eating disorder symptomatology, will also be used to assess this outcome. The total score ranges from 0 (least severe) to 50 (most severe).

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  7. Changes in parental self-efficacy

    Changes in parental self-efficacy will be assessed using the "Parents versus Eating Disorder Scale" (PvED), a 7-item measure assessing parental self-efficacy related to re-feeding their child with an eating disorder. Scores range from 7 (least severe) to 35 (most severe).

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  8. Provider's readiness for change

    Provider individual readiness for change will be evaluated using the Brief Individual Readiness for Change Scale (BIRCS), administered to therapist-coaches. Minimum score is 0, maximum score is 20.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  9. Providers' attitudes towards evidence-based practice

    Provider attitudes about evidence-based practice will be assessed using the Evidence Based Practice Attitudes Scale (EBPAS), administered to therapist-coaches. Minimum score for each subscale is 0, maximum score for each subscale is 4.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

  10. Provider's confidence in ability to deliver intervention

    Confidence related to the intervention will be assessed by administering an adapted version of the Perceived Attributes of the Principles of Effectiveness Scale (MPAQ) to therapist-coaches. The minimum score is 18, the maximum score is 90.

    Time frame: at the baseline (week 0) and at the end of treatment (24 weeks)

Other outcomes

  1. The experience of parents/families participating in GSH FBT treatment

    Semi-structured interviews will be used to elicit qualitative descriptions of experiences of each family participating in GSH FBT treatment.

    Time frame: Interviews with families will be scheduled within two weeks of their provider notifying us that their final treatment session has occurred.

  2. Implementation teams' experiences of GSH FBT treatment and its implementation

    Semi-structured focus groups with each site's implementation team will be used to elicit qualitative descriptions of their experiences of GSH FBT treatment and implementation.

    Time frame: Focus groups with a site will occur within two weeks of when the investigators have been notified that all GSH FBT sessions have been completed at the site.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Couturier J, Smith J, Nicula M, Nella E, Yanover T, Agostino H, Annema S, Boman J, Bond J, Coelho JS, Coolen AM, Datta N, Dimitropoulos G, Ford C, Isserlin L, Johnson N, Jones S, Katzman D, Kelly B, Keshen A, Kimber M, Kumar S, Kurji A, Lacroix E, Markland A, Matheson B, McVey G, McQuillan B, Norris M, Obeid N, Phillips S, Preskow W, Rodrigues A, Smith S, Soroka C, Spettigue W, Webb C, Wournell J, Lock JD. National implementation of guided self-help family-based treatment for youth with eating disorders: a study protocol. BMC Psychiatry. 2025 Nov 6;25(1):1066. doi: 10.1186/s12888-025-07545-1. PubMed 41199206 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Aug 2027, 16 months after the start.

Of 267 non-industry interventional studies with no phase under Feeding and Eating Disorders, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 49. This study's planned 16 months is below that.

Counting every sponsor, half of 272 studies reached it within 28 months; a quarter within 14 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2025
First posted
Feb 28, 2025
StartActual
Apr 28, 2026
Primary completionEst.
Aug 30, 2027
CompletionEst.
Dec 30, 2027
Last update
May 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06851273
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Jennifer Couturier (Principal Investigator, McMaster University) — Principal investigator
First posted
Feb 28, 2025
Start date
Apr 28, 2026
Primary completion
Aug 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
May 7, 2026

Study contacts

Jennifer Couturier, MSc, MD
Contact
coutur@mcmaster.ca
905-521-2100 ext. 76008

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion